Sage Journals: Discover world-class research

Open access

Research article

First published 2022

Cytoreductive Surgery (CRS) Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Platinum-Sensitive Recurrence Epithelial Ovarian Cancer With HRR Mutation: A Phase III Randomized Clinical Trial

Yuwen Qi, Yaxing Zhang, Yuying Shi [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2023

Oxaliplatin prior to PARP inhibitor in BRCA-mutated ovarian cancer

Maria Ornella Nicoletto, Alessandra Baldoni, Francesco Cavallin [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2018

A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet

Hope Cottrill, Stephanie Cason, Scott Caroen [...]

Journal of Investigative Medicine High Impact Case Reports

Free access

Research article

First published 2007-5

Role of Gemcitabine in the Treatment of Ovarian Cancer

Fadi AbuShahin, Peter G Rose

Women's Health

Open access

Research article

First published 2021-9

Puerarin induces platinum-resistant epithelial ovarian cancer cell apoptosis by targeting SIRT1

Jianxiu Duan, Mingyuan Yin, Yaqin Shao [...]

Journal of International Medical Research

Retricted access

Research article

First published 2011-09

Radiation therapy is a treatment to be considered for recurrent epithelial ovarian cancer after chemotherapy

Shin-Wha Lee, Sang-Min Park, Yong-Man Kim [...]

Tumori Journal

Free access

Review article

First published 2009-9

Hereditary Ovarian Cancer: Biology,Response to Chemotherapy and Prognosis

Tamar Safra

Women's Health

Retricted access

Review article

First published 2016-9

The Current Status of PARP Inhibitors in Ovarian Cancer

Jennifer McLachlan, Angela George, Susana Banerjee

Tumori Journal

Open access

Research article

First published 2019

Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts

Francesca Ricci, Laura Brunelli, Roberta Affatato [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2006-7

Pre-Treatment Prediction of Chemoresistance in Second-Line Chemotherapy of Ovarian Carcinoma: Value of Serological Tumor Marker Determination (Tetranectin,YKL-40,CASA,CA 125)

B. Gronlund, E.V.S. Høgdall, I.J. Christensen [...]

The International Journal of Biological Markers

Search results